These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2067585)

  • 1. Identification of 5-hydroxytryptamine1A receptor agents using a composite pharmacophore analysis and chemical database screening.
    Sleight AJ; Peroutka SJ
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):109-16. PubMed ID: 2067585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivity.
    Harrington MA; Sleight AJ; Pitha J; Peroutka SJ
    Eur J Pharmacol; 1991 Feb; 194(1):83-90. PubMed ID: 2060596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional steric molecular modeling of the 5-hydroxytryptamine3 receptor pharmacophore.
    Schmidt AW; Peroutka SJ
    Mol Pharmacol; 1989 Oct; 36(4):505-11. PubMed ID: 2811853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
    Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP
    J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
    Schoeffter P; Hoyer D
    Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
    Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C; Vallgårda J; Nelson DL; Björk L; Yu H; Andén NE; Csöregh I; Arvidsson LE; Hacksell U
    J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor.
    Hibert MF; Gittos MW; Middlemiss DN; Mir AK; Fozard JR
    J Med Chem; 1988 Jun; 31(6):1087-93. PubMed ID: 3373482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
    Oksenberg D; Peroutka SJ
    Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
    Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
    J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCS-MPP (4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-isothiocyanobenz amido]-ethyl-piperazine): a high affinity and irreversible 5-HT1A receptor ligand.
    Kung MP; Mu M; Zhuang ZP; Kung HF
    Life Sci; 1996; 58(3):177-86. PubMed ID: 9499158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
    Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
    J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.